rpt193,cendakimab,cbp-201,lebrikizumab,etrasimod,nemolizumab,amlitelimab sar445229
amgen,pfizer,rapt therapeutics,galderma,sanofi,eli lilly,connect biopharma,bms
['ky1005', 'rpt193', 'etrasimod ', 'lebri,(-celebri)', 'amlitelimab', 'cendakimab', 'cbp201', 'nemolizumab', 'derm', 'pfizer', 'kymab', 'dermira', 'connect bio', 'sanofi', 'bms', 'amgen', ' lilly']
the therapeutic drought is finally ending. hot topics: atopic dermatitis, new developments: what s in the pipeline for patients? + can the translational revolution in ad also extend to #alopeciaareata? explored by dr. at #aad2023. #dermtwitter 
An international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for @MountSinaiNYC.